These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3037173)

  • 1. Heart failure, renal function, and angiotensin converting enzyme inhibitors.
    Cleland JG; Dargie HJ
    Kidney Int Suppl; 1987 May; 20():S220-8. PubMed ID: 3037173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
    Dzau VJ
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):74-80. PubMed ID: 3037893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of the angiotensin-converting enzyme--effect on kidney function and electrolyte balance].
    Kramer HJ
    Z Kardiol; 1988; 77 Suppl 3():39-45. PubMed ID: 3062959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin converting enzyme inhibition and autoregulation of glomerular filtration.
    Plante GE; Chainey A; Sirois P; Devissaguet M
    J Hypertens Suppl; 1988 Dec; 6(3):S69-73. PubMed ID: 3066878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the renal nerves and angiotensin II in the renal function curve.
    Golin R; Genovesi S; Castoldi G; Wijnmaalen P; Protasoni G; Zanchetti A; Stella A
    Arch Ital Biol; 1999 Aug; 137(4):289-97. PubMed ID: 10443320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole kidney response to reduced arterial pressure during converting enzyme inhibition in the rat.
    Göransson A; Isaksson B; Sjöquist M
    Ren Physiol; 1986; 9(5):287-301. PubMed ID: 3544107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal haemodynamics and function in weanling rats treated with enalapril from birth.
    Guron G
    Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):865-70. PubMed ID: 16173949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal hemodynamic consequences of angiotensin-converting enzyme inhibition in congestive heart failure.
    Suki WN
    Arch Intern Med; 1989 Mar; 149(3):669-73. PubMed ID: 2537612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition.
    Reams GP; Singh A; Logan KW; Holmes RA; Bauer JH
    J Clin Hypertens; 1987 Jun; 3(2):153-63. PubMed ID: 3039075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril in heart failure: a double-blind study of the effects on renal function.
    Cleland JG; Dargie HJ; Gillen G; Robertson I; East BW; Ball SG; Morton JJ; Robertson JI
    J Cardiovasc Pharmacol; 1986; 8(4):700-6. PubMed ID: 2427807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in renal function in heart failure and their modification by conversion enzyme inhibitors].
    Heidland A; Teschner M; Götz R
    Klin Wochenschr; 1991; 69 Suppl 24():65-72; discussion 72-4. PubMed ID: 1865635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
    Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
    J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
    Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
    Seymour AA; Asaad MM; Lanoce VM; Langenbacher KM; Fennell SA; Rogers WL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal response to pentobarbital anesthesia in rats: effect of interrupting the renin-angiotensin system.
    Walker LA; Gellai M; Valtin H
    J Pharmacol Exp Ther; 1986 Mar; 236(3):721-8. PubMed ID: 3512818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension.
    O'Connor DT; Mosley CA; Cervenka J; Bernstein KN
    J Hypertens Suppl; 1984 Dec; 2(2):S89-92. PubMed ID: 6100882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal failure related to angiotensin-converting enzyme inhibitors.
    Textor SC
    Semin Nephrol; 1997 Jan; 17(1):67-76. PubMed ID: 9000551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
    Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
    Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.